209 related articles for article (PubMed ID: 16480334)
41. A high-affinity T-helper epitope enhances peptide-pulsed dendritic cell-based vaccine.
Li A; Xiong S; Lin Y; Liu R; Chu Y
DNA Cell Biol; 2011 Nov; 30(11):883-92. PubMed ID: 21612399
[TBL] [Abstract][Full Text] [Related]
42. Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.
Hu J; Yuan X; Belladonna ML; Ong JM; Wachsmann-Hogiu S; Farkas DL; Black KL; Yu JS
Cancer Res; 2006 Sep; 66(17):8887-96. PubMed ID: 16951206
[TBL] [Abstract][Full Text] [Related]
43. Naive CD8(+) but not CD4(+) T cells induce maturation of dendritic cells.
Schüler T; Blankenstein T
J Mol Med (Berl); 2002 Aug; 80(8):533-41. PubMed ID: 12185454
[TBL] [Abstract][Full Text] [Related]
44. CD8alpha+ dendritic cells enhance the antigen-specific CD4+ T-cell response and accelerate development of collagen-induced arthritis.
Jung YO; Min SY; Cho ML; Park MJ; Jeon JY; Lee JS; Oh HJ; Kang CM; Park HS; Park KS; Cho SG; Park SH; Kim HY
Immunol Lett; 2007 Aug; 111(2):76-83. PubMed ID: 17610959
[TBL] [Abstract][Full Text] [Related]
45. Differential capacity of CD8+ alpha or CD8- alpha dendritic cell subsets to prime for eosinophilic airway inflammation in the T-helper type 2-prone milieu of the lung.
Hammad H; de Vries VC; Maldonado-Lopez R; Moser M; Maliszewski C; Hoogsteden HC; Lambrecht BN
Clin Exp Allergy; 2004 Dec; 34(12):1834-40. PubMed ID: 15663556
[TBL] [Abstract][Full Text] [Related]
46. A novel T cell-based vaccine capable of stimulating long-term functional CTL memory against B16 melanoma via CD40L signaling.
Xie Y; Wang L; Freywald A; Qureshi M; Chen Y; Xiang J
Cell Mol Immunol; 2013 Jan; 10(1):72-7. PubMed ID: 23042534
[TBL] [Abstract][Full Text] [Related]
47. Delivery of interferon-alpha transfected dendritic cells into central nervous system tumors enhances the antitumor efficacy of peripheral peptide-based vaccines.
Okada H; Tsugawa T; Sato H; Kuwashima N; Gambotto A; Okada K; Dusak JE; Fellows-Mayle WK; Papworth GD; Watkins SC; Chambers WH; Potter DM; Storkus WJ; Pollack IF
Cancer Res; 2004 Aug; 64(16):5830-8. PubMed ID: 15313927
[TBL] [Abstract][Full Text] [Related]
48. Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells.
Koido S; Hara E; Torii A; Homma S; Toyama Y; Kawahara H; Ogawa M; Watanabe M; Yanaga K; Fujise K; Gong J; Toda G
Int J Cancer; 2005 Nov; 117(4):587-95. PubMed ID: 15945098
[TBL] [Abstract][Full Text] [Related]
49. Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor.
Chen Z; Huang H; Chang T; Carlsen S; Saxena A; Marr R; Xing Z; Xiang J
Cancer Gene Ther; 2002 Sep; 9(9):778-86. PubMed ID: 12189528
[TBL] [Abstract][Full Text] [Related]
50. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.
Hokey DA; Larregina AT; Erdos G; Watkins SC; Falo LD
Cancer Res; 2005 Nov; 65(21):10059-67. PubMed ID: 16267032
[TBL] [Abstract][Full Text] [Related]
51. Dexamethasone turns tumor antigen-presenting cells into tolerogenic dendritic cells with T cell inhibitory functions.
Falcón-Beas C; Tittarelli A; Mora-Bau G; Tempio F; Pérez C; Hevia D; Behrens C; Flores I; Falcón-Beas F; Garrido P; Ascui G; Pereda C; González FE; Salazar-Onfray F; López MN
Immunobiology; 2019 Sep; 224(5):697-705. PubMed ID: 31221438
[TBL] [Abstract][Full Text] [Related]
52. Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells.
Li HS; Liu C; Xiao Y; Chu F; Liang X; Peng W; Hu J; Neelapu SS; Sun SC; Hwu P; Watowich SS
Sci Signal; 2016 Sep; 9(447):ra94. PubMed ID: 27678219
[TBL] [Abstract][Full Text] [Related]
53. Ascophyllan functions as an adjuvant to promote anti-cancer effect by dendritic cell activation.
Zhang W; Okimura T; Xu L; Zhang L; Oda T; Kwak M; Yu Q; Jin JO
Oncotarget; 2016 Apr; 7(15):19284-98. PubMed ID: 27008707
[TBL] [Abstract][Full Text] [Related]
54. Adrenergic modulation of dendritic cell cancer vaccine in a mouse model: role of dendritic cell maturation.
Botta F; Maestroni GJ
J Immunother; 2008 Apr; 31(3):263-70. PubMed ID: 18317361
[TBL] [Abstract][Full Text] [Related]
55. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.
Boczkowski D; Nair SK; Snyder D; Gilboa E
J Exp Med; 1996 Aug; 184(2):465-72. PubMed ID: 8760800
[TBL] [Abstract][Full Text] [Related]
56. Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines.
Wen CC; Chen HM; Chen SS; Huang LT; Chang WT; Wei WC; Chou LC; Arulselvan P; Wu JB; Kuo SC; Yang NS
J Biomed Sci; 2011 Jun; 18(1):44. PubMed ID: 21689407
[TBL] [Abstract][Full Text] [Related]
57. Adjuvant combination and antigen targeting as a strategy to induce polyfunctional and high-avidity T-cell responses against poorly immunogenic tumors.
Aranda F; Llopiz D; Díaz-Valdés N; Riezu-Boj JI; Bezunartea J; Ruiz M; Martínez M; Durantez M; Mansilla C; Prieto J; Lasarte JJ; Borrás-Cuesta F; Sarobe P
Cancer Res; 2011 May; 71(9):3214-24. PubMed ID: 21402711
[TBL] [Abstract][Full Text] [Related]
58. Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells.
Kalergis AM; Ravetch JV
J Exp Med; 2002 Jun; 195(12):1653-9. PubMed ID: 12070293
[TBL] [Abstract][Full Text] [Related]
59. Impaired dendritic cell function in aging leads to defective antitumor immunity.
Grolleau-Julius A; Harning EK; Abernathy LM; Yung RL
Cancer Res; 2008 Aug; 68(15):6341-9. PubMed ID: 18676859
[TBL] [Abstract][Full Text] [Related]
60. A crucial role for retinoic acid in the development of Notch-dependent murine splenic CD8- CD4- and CD4+ dendritic cells.
Beijer MR; Molenaar R; Goverse G; Mebius RE; Kraal G; den Haan JM
Eur J Immunol; 2013 Jun; 43(6):1608-16. PubMed ID: 23519987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
